FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: General Motors Rehires Over 100 Former Cruise Team Members

By

General Motors (GM) has rehired more than 100 members of its Cruise unit's team 18 months after killing off the self-driving vehicle unit, The Information Electric reported Thursday, citing Rashed Haq, GM's vice president of autonomous vehicles.

The hiring spree, which also includes workers hired away from Nvidia (NVDA), Uber Technologies (UBER) and Amazon's (AMZN) Zoox, reflects the company's move toward self-driving cars for consumers' personal use and away from the driverless ride-hailing business, Haq said, according to the report.

The reconstituted group's first project will be an electric Cadillac that allows the driver to operate the car on highways while not touching the wheel or watching the road, the report said. GM plans to release it in 2028, with additional models to follow, the report added.

GM didn't immediately reply to a request for comment from.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: $83.50, Change: $+1.80, Percent Change: +2.20%

Related Articles

Wire

Veru Enters Supply Agreement With Novo Nordisk for Obesity Study; Shares Surge

Veru (VERU) said Thursday in a regulatory filing that it entered a clinical supply agreement with Novo Nordisk (NVO) to support its phase 2b PLATEAU study evaluating enobosarm in combination with Novo's Wegovy in older adults with obesity undergoing weight loss treatment.Under the agreement, Novo Nordisk will provide Wegovy free of charge for the study, while Veru will sponsor and conduct the trial and share clinical study updates and insights related to obesity and weight management research, the filing shows.Veru said it retains global development and commercialization rights to enobosarm, while Novo Nordisk received a right of first negotiation if Veru seeks to develop, commercialize or license enobosarm in combination with Novo Nordisk GLP-1 products in the future.Shares of Veru rose 155% in Thursday trading.Price: $5.52, Change: $+3.27, Percent Change: +145.47%

$NVO$VERU
Wire

General Motors Rehires Over 100 Former Cruise Team Members, The Information Reports

General Motors Rehires Over 100 Former Cruise Team Members, The Information Reports

$GM
Wire

Market Chatter: Merck to Pay Over $50 Million to Settle More Than 200 Gardasil Cases

Merck (MRK) said Thursday it will pay over $50 million to settle more than 200 lawsuits that blame the drugmaker's Gardasil cancer vaccine for causing autoimmune ailments in young women, Bloomberg reported, citing an emailed statement from the company.Gardasil prevents human papillomavirus infections. The lawsuits allege it can cause autoimmune conditions affecting the heart and reproductive systems in young women, according to the report.Merck didn't immediately reply to a request for comment from.Price: $119.28, Change: $+4.58, Percent Change: +3.99%

$MRK